Psilocybin, an indoleamine hallucinogen, produces a psychosis-like syndrome in humans that resembles first episodes of schizophrenia. In healthy human volunteers, the psychotomimetic effects of psilocybin were blocked dose-dependently by the serotonin-2A antagonist ketanserin or the atypical antipsychotic risperidone, but were increased by the dopamine antagonist and typical antipsychotic haloperidol. These data are consistent with animal studies and provide the first evidence in humans that psilocybin-induced psychosis is due to serotonin-2A receptor activation, independently of dopamine stimulation. Thus, serotonin-2A overactivity may be involved in the pathophysiology of schizophrenia and serotonin-2A antagonism may contribute to therapeutic effects of antipsychotics.
SYNOPSISWhile much is now known about the operation and organisation of the brain at the neuronal and microcircuit level, we are still some way from understanding it as a complete system from the lowest to the highest levels of description. One way to gain such an integrative understanding of neural systems is to construct them. We have built the largest neuromorphic system yet known, an interactive space called 'Ada' that is able to interact with many people simultaneously using a wide variety of sensory and behavioural modalities. 'She' received 553,700 visitors over 5 months during the Swiss Expo.02 in 2002. In this paper we present the broad motivations, design and technologies behind Ada, and discuss the construction and analysis of the system.
Despite immense progress in neuroscience, we remain restricted in our ability to construct autonomous, behaving robots that match the competence of even simple animals. The barriers to the realisation of this goal include lack of knowledge of system integration issues, engineering limitations and the organisational constraints common to many research laboratories. In this paper we describe our approach to addressing these issues by constructing an artificial organism within the framework of the Ada projecta large-scalepublic exhibit for the Swiss Exp0.02 national exhibition.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.